Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Interventional × Acupuncture Points × Clear all

Phase

Phase NA 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Patient Compliance 1

Interventions

Cisplatin 1271 Carboplatin 1188 Cyclophosphamide 1135 Gemcitabine 1033 Paclitaxel 1018 Bevacizumab 1018 Radiotherapy 1001 Docetaxel 935 pembrolizumab 867 Oxaliplatin 780 Capecitabine 764 Fluorouracil 718 Rituximab 627 Doxorubicin 566 Dexamethasone 561 Nivolumab 558 Etoposide 557 Irinotecan 537 Leucovorin 496 Pemetrexed 426 Drug Therapy 406 Cytarabine 400 Cetuximab 400 Trastuzumab 392 Filgrastim 375 Magnetic Resonance Spectroscopy 368 Prednisone 362 Lenalidomide 344 Bortezomib 339 Temozolomide 331

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04749381 2021-02-11

RCT

Peking University Cancer Hospital & Institute

Phase 2 Unknown

Gastrointestinal

Patient Compliance, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡